Skip to main content
. 2020 Sep 2;11:2067. doi: 10.3389/fimmu.2020.02067

Table 1.

Comparison of four epitope mapping techniques that consider the three-dimensional structure of the allergen: X-ray crystallography, NMR, cryo-EM and mass spectrometry.

X-ray crystallography Nuclear magnetic resonance
• Crystalline state, however, the crystals contain ~30–70% of disordered solvent • Solution conditions (requires weeks of stability for data collection).
• Theoretically no structure size limit
• Proteins purified from natural sources can be used
• High resolution structures up to ~30 kDa.
• Expression with isotope is typically not required for proteins or DNA. Sometimes selenomethionine is incorporated instead of Met. • Protein/DNA samples usually require 13C and 15N labeling (stable isotopes). Cost of expression is prohibitive except in prokaryotes.
• X-rays diffraction data are recorded, and the diffraction patterns are used to calculate initial electron density maps. The maps are used to trace a model of the macromolecule, that is later refined and validated • Data is nuclear resonance frequencies of primarily 1H, 13C, and 15N. Distances between 1H atoms are used to build ensembles of possible structures.
• Highly flexible/disordered regions of proteins cannot be modeled and are absent in the final models • Motion and disorder can be directly measured on many time scales.
Mass spectrometry Cryo-electron microscopy
• Typically used in protection assays for epitope mapping.
• High sensitivity/low sample requirements.
• Atomic resolution identifies specific residues for protection from modification.
• Residues that are convenient to modify in protection assays are not always useful for epitope mapping.
• Chemistry of modification procedures can have off target effects.
• Can determine atomic resolution structures frozen from solution in vitreous ice.
• Low sample requirements.
• Resolution occasionally as good as X-ray crystallography.
• Performs better on very large samples with high symmetry, typically 100's of kDa, so it is currently not easily or generally applicable to allergen epitope mapping.